The Ministry of Health, with support from the Global Fund, its Principal Recipient Plan International Liberia, and other health sector partners, is holding a one-day workshop in Liberia focused on tuberculosis (TB) interventions. This workshop aims to evaluate the current status of TB response efforts in Liberia, address key challenges, and develop strategies to strengthen the country’s TB interventions.
The agenda includes presentations covering TB prevalence in Liberia, diagnostic and treatment practices, and service quality. Attendees include investment partners from the Global Fund, healthcare providers specializing in TB, and various other stakeholders.
This workshop aligns with a concurrent high-level visit from the Global Fund Africa delegation to Liberia, aimed at reviewing health sector investments, particularly TB-focused efforts. The delegation has met with officials from the Ministry of Health and the Liberia Coordinating Mechanism, the body responsible for overseeing Global Fund activities in Liberia.
In July 2024, H.E. President Joseph Nyuma Boakai, President of the Republic of Liberia, officially launched the Global Fund Grant Cycle Seven (GC7) in Monrovia. This cycle covers multiple integrated grants, including those for HIV and TB programs, Resilient Health System Strengthening (RHSS), COVID-19 (C-19RM), and malaria interventions. The grants, totaling US$117,546,670, are designated to support key initiatives under the Global Fund’s new funding framework for 2024-2026.
The GC7 funding focuses on national programs for HIV, TB, Malaria, and COVID-19 response, alongside efforts to strengthen Liberia’s health systems. Notably, it also includes a Wave 2 COVID-19 investment aimed at bolstering the country’s resilience and preparedness. This funding is a crucial step forward for Liberia in advancing health security and addressing priority health needs.
Through its partnership with Liberia, the Global Fund has for nearly two decades resolutely supported the country in improving its health systems and combating diseases, especially HIV/AIDS, Malaria, and Tuberculosis. The Global Fund’s high-level visit this week further boosts the rollout of the GC-7 and C-19 RM grants and promises enormous outcomes in the fight against TB in Liberia.
